SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-14 Cr | ₹-242 Cr | ₹-156 Cr | ₹-76 Cr | ₹7.32 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-14 Cr |
Mar2023 | ₹-242 Cr |
Mar2022 | ₹-156 Cr |
Mar2021 | ₹-76 Cr |
Mar2020 | ₹7.32 Cr |
How is Cash Flow from Financing Activities of SUVEN PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-14 Cr | Negative | |
Mar2023 | ₹-242 Cr | Negative | |
Mar2022 | ₹-156 Cr | Negative | |
Mar2021 | ₹-76 Cr | Negative | |
Mar2020 | ₹7.32 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,478.3 Cr | -1.4% | 6.5% | 82.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | -2% | -0.8% | 16.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | -2.7% | 3.5% | 66.7% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 0.7% | 1.4% | 3.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 0.1% | -8.5% | 0.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | -0.9% | -1% | 24% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -1.4% |
6.5% |
82.5% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses